RGNX Regenxbio: Net earnings per share growth forecast for next year

REGENXBIO Inc (RGNX) - corporate logo

The success of REGENXBIO Inc. (RGNX) depends on clinical results rather than market cycles. The one-year forward EPS growth rate demonstrates the resilience of the stock price, where 4.90 becomes the new value of the metric. Leadership in AAV vectors and geopolitical neutrality strengthen the financial foundation, guaranteeing the stability of gene therapy development for rare pathologies.

RGNX - REGENXBIO Inc Expected earnings per share trend next year over the range 07/04/2022 - 11/17/2026

Analytical breakdowns for REGENXBIO (RGNX)

- share price and consensus valuation forecast:
- company stock capitalization data:
Comprehensive company analysis:regenxbio.com
Core merchandise of regenxbio.com

The stable staffing of the R&D division at REGENXBIO Inc. (RGNX) ensures predictability in drug development, which is reflected in the one-year forward EPS growth rate. This metric measures the expected earnings momentum over the next twelve-month horizon according to expert consensus. The narrowing amplitude of the curve signals a stabilization of operating income and the formation of a sustainable market forecast. Such a pattern confirms strong fundamental investor confidence in the capitalization of the company's intellectual assets.

Competitor analysis

TEM (Tempus) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year QGEN (Qiagen)|Earnings growth forecast for next year IONS|RGEN (Repligen) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year aviditybiosciences.com RNA|CRISPR (CRSP) - Expected net earnings per share growth next year|genedx.com - Earnings growth forecast for next year|Expected earnings per share trend next year RARE (ultragenyx.com)|BEAM: Earnings growth forecast for next year|Sarepta - Expected earnings per share trend next year|TWST (twistbioscience.com) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year TXG (10x Genomics Corp)|Earnings growth forecast for next year NTLA|Earnings growth forecast for next year Stoke Therapeutics, Inc. (STOK)|Net earnings per share growth forecast for next year BioLife BLFS|WVE - Expected earnings per share growth for next year|Maze Therapeutics Corp - Earnings growth forecast for next year|Sionna Pharma - Projected earnings per share increase next year|Prime Medicine (PRME) - Net earnings per share growth forecast for next year|tayshagtx.com (TSHA) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year uniQure Corp|MGTX: Expected earnings per share trend next year|Earnings growth forecast for next year SLDB|OCGN - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Pacific Biosciences of California PACB|BNTC: Projected earnings per share growth rate for next year|DSGN - Net earnings per share growth forecast for next year|RCKT: Net earnings per share growth forecast for next year|FDMT - Projected earnings per share increase next year|Expected net earnings per share growth next year Lexeo Therapeutics Inc. (LXEO)|Net earnings per share growth forecast for next year Korro Bio Inc.|Editas Medicine (EDIT) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Silence Therapeutics Inc. (SLN)|PRQR: Net earnings per share change forecast for next year|Earnings growth forecast for next year CDXS (codexis.com)|SGMO: Projected earnings per share growth rate for next year|NAUT: Expected earnings per share growth for next year|Expected net earnings per share growth next year metagenomi.co|Precision BioSciences, Inc. (DTIL) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Generation Bio Corp (GBIO)|Expected earnings per share growth for next year BOLD|exicuretx.com (XCUR) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year IMNN (Celsion Corporation)|PHIO (Phio Pharmaceuticals Corp.) - Expected earnings per share trend next year|Earnings growth forecast for next year MBIO (Mustang Bio Corp)|Projected earnings per share increase next year RNAZ (TransCode Therapeutics)|BNGO - Net earnings per share growth forecast for next year|APDN: Net earnings per share growth forecast for next year|BLUE: Earnings growth forecast for next year|Expected earnings per share growth for next year ImmunoPrecise Antibodies|OMGA (Omega Therapeutics, Inc.) - Earnings growth forecast for next year|Singular Genomics (OMIC) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Regulus (RGLS)|SYRS (Syros Pharmaceuticals, Inc) - Expected earnings per share trend next year|Telesis Bio, Inc. - Expected earnings per share growth for next year|TCON: Projected earnings per share growth rate for next year|Unity Biotechnology Inc. - Earnings growth forecast for next year